Free Trial
NYSE:GRDN

Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Guardian Pharmacy Services logo
$24.14 +0.05 (+0.21%)
Closing price 03:59 PM Eastern
Extended Trading
$24.16 +0.02 (+0.06%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Guardian Pharmacy Services Stock (NYSE:GRDN)

Key Stats

Today's Range
$23.73
$24.64
50-Day Range
$18.37
$24.13
52-Week Range
$14.16
$25.74
Volume
45,382 shs
Average Volume
151,193 shs
Market Capitalization
$1.53 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.33
Consensus Rating
Buy

Company Overview

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Guardian Pharmacy Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

GRDN MarketRank™: 

Guardian Pharmacy Services scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Guardian Pharmacy Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Guardian Pharmacy Services has only been the subject of 1 research reports in the past 90 days.

  • Read more about Guardian Pharmacy Services' stock forecast and price target.
  • Short Interest

    There is no current short interest data available for GRDN.
  • Dividend Yield

    Guardian Pharmacy Services does not currently pay a dividend.

  • Dividend Growth

    Guardian Pharmacy Services does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for GRDN.
  • News Sentiment

    Guardian Pharmacy Services has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    4 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Guardian Pharmacy Services' insider trading history.
Receive GRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter.

GRDN Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Guardian Pharmacy reports Q4 EPS 19c, consensus 22c
See More Headlines

GRDN Stock Analysis - Frequently Asked Questions

Guardian Pharmacy Services' stock was trading at $20.26 on January 1st, 2025. Since then, GRDN shares have increased by 20.5% and is now trading at $24.4050.
View the best growth stocks for 2025 here
.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) released its earnings results on Tuesday, November, 12th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $0.19 by $2.19. The firm had revenue of $314.39 million for the quarter, compared to analysts' expectations of $303.21 million.
Read the conference call transcript
.

Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO.

Guardian Pharmacy Services' lock-up period expired on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Top institutional investors of Guardian Pharmacy Services include Allspring Global Investments Holdings LLC (0.45%), Peregrine Capital Management LLC (0.28%) and GAMMA Investing LLC. Insiders that own company stock include Thomas J Salentine Jr and Steven D Cosler.
View institutional ownership trends
.

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META).

Company Calendar

Last Earnings
11/12/2024
Today
4/25/2025
Next Earnings (Estimated)
6/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
Retail
Current Symbol
NYSE:GRDN
Previous Symbol
NYSE:GRDN
Fax
N/A
Employees
3,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.33
High Stock Price Target
$25.00
Low Stock Price Target
$21.00
Potential Upside/Downside
-8.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.23 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.54 billion
Optionable
N/A
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:GRDN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners